These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 30323949)

  • 1. Biomechanics show stem cell necessity for effective treatment of volumetric muscle loss using bioengineered constructs.
    Quarta M; Cromie Lear MJ; Blonigan J; Paine P; Chacon R; Rando TA
    NPJ Regen Med; 2018; 3():18. PubMed ID: 30323949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioengineered constructs combined with exercise enhance stem cell-mediated treatment of volumetric muscle loss.
    Quarta M; Cromie M; Chacon R; Blonigan J; Garcia V; Akimenko I; Hamer M; Paine P; Stok M; Shrager JB; Rando TA
    Nat Commun; 2017 Jun; 8():15613. PubMed ID: 28631758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aligned nanofibers of decellularized muscle extracellular matrix for volumetric muscle loss.
    Patel KH; Talovic M; Dunn AJ; Patel A; Vendrell S; Schwartz M; Garg K
    J Biomed Mater Res B Appl Biomater; 2020 Aug; 108(6):2528-2537. PubMed ID: 32052931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A tissue engineering approach for repairing craniofacial volumetric muscle loss in a sheep following a 2, 4, and 6-month recovery.
    Rodriguez BL; Vega-Soto EE; Kennedy CS; Nguyen MH; Cederna PS; Larkin LM
    PLoS One; 2020; 15(9):e0239152. PubMed ID: 32956427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-Time Functional Assay of Volumetric Muscle Loss Injured Mouse Masseter Muscles via Nanomembrane Electronics.
    Kim H; Kwon YT; Zhu C; Wu F; Kwon S; Yeo WH; Choo HJ
    Adv Sci (Weinh); 2021 Sep; 8(17):e2101037. PubMed ID: 34218527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 3D cell printed muscle construct with tissue-derived bioink for the treatment of volumetric muscle loss.
    Choi YJ; Jun YJ; Kim DY; Yi HG; Chae SH; Kang J; Lee J; Gao G; Kong JS; Jang J; Chung WK; Rhie JW; Cho DW
    Biomaterials; 2019 Jun; 206():160-169. PubMed ID: 30939408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Codelivery of Infusion Decellularized Skeletal Muscle with Minced Muscle Autografts Improved Recovery from Volumetric Muscle Loss Injury in a Rat Model.
    Kasukonis B; Kim J; Brown L; Jones J; Ahmadi S; Washington T; Wolchok J
    Tissue Eng Part A; 2016 Oct; 22(19-20):1151-1163. PubMed ID: 27570911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A standardized rat model of volumetric muscle loss injury for the development of tissue engineering therapies.
    Wu X; Corona BT; Chen X; Walters TJ
    Biores Open Access; 2012 Dec; 1(6):280-90. PubMed ID: 23515319
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Li MT; Ruehle MA; Stevens HY; Servies N; Willett NJ; Karthikeyakannan S; Warren GL; Guldberg RE; Krishnan L
    Tissue Eng Part A; 2017 Sep; 23(17-18):989-1000. PubMed ID: 28372522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular matrix scaffolds for treatment of large volume muscle injuries: A review.
    Sarrafian TL; Bodine SC; Murphy B; Grayson JK; Stover SM
    Vet Surg; 2018 May; 47(4):524-535. PubMed ID: 29603757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decellularized Tissue for Muscle Regeneration.
    Urciuolo A; De Coppi P
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30110909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skeletal Muscle Tissue Engineering: Biomaterials-Based Strategies for the Treatment of Volumetric Muscle Loss.
    Carnes ME; Pins GD
    Bioengineering (Basel); 2020 Jul; 7(3):. PubMed ID: 32751847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Potential of Combination Therapeutics for More Complete Repair of Volumetric Muscle Loss Injuries: The Role of Exogenous Growth Factors and/or Progenitor Cells in Implantable Skeletal Muscle Tissue Engineering Technologies.
    Passipieri JA; Christ GJ
    Cells Tissues Organs; 2016; 202(3-4):202-213. PubMed ID: 27825153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined application of biosponges and an antifibrotic agent for the treatment of volumetric muscle loss.
    West C; Tobo C; Au J; Johnson D; Mottaleb MA; Robinson J; Shringarpure S; Griggs DW; Garg K
    Am J Physiol Cell Physiol; 2023 Jun; 324(6):C1341-C1352. PubMed ID: 37184231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis and Modeling of Rat Gait Biomechanical Deficits in Response to Volumetric Muscle Loss Injury.
    Dienes JA; Hu X; Janson KD; Slater C; Dooley EA; Christ GJ; Russell SD
    Front Bioeng Biotechnol; 2019; 7():146. PubMed ID: 31275932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asynchronous inflammation and myogenic cell migration limit muscle tissue regeneration mediated by a cellular scaffolds.
    Garg K; Ward CL; Corona BT
    Inflamm Cell Signal; 2014; 1(4):. PubMed ID: 26949720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Approaches for Volumetric Muscle Loss Injury: A Systematic Review and Meta-Analysis.
    Greising SM; Corona BT; McGann C; Frankum JK; Warren GL
    Tissue Eng Part B Rev; 2019 Dec; 25(6):510-525. PubMed ID: 31578930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous Effects of High Intensity Interval Training and Human Amniotic Membrane Scaffold on Rat Tibialis Anterior Vascularization and Innervation after Volumetric Muscle Loss Injury.
    Izadi MR; Habibi A; Khodabandeh Z; Nikbakht M
    Int J Organ Transplant Med; 2021; 12(1):33-43. PubMed ID: 34987731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Encapsulation of bone marrow-MSCs in PRP-derived fibrin microbeads and preliminary evaluation in a volumetric muscle loss injury rat model: modular muscle tissue engineering.
    Lalegül-Ülker Ö; Şeker Ş; Elçin AE; Elçin YM
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):10-21. PubMed ID: 30514127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stem cells and extracellular matrix scaffold promote muscle regeneration by synergistically regulating macrophage polarization toward the M2 phenotype.
    Qiu X; Liu S; Zhang H; Zhu B; Su Y; Zheng C; Tian R; Wang M; Kuang H; Zhao X; Jin Y
    Stem Cell Res Ther; 2018 Apr; 9(1):88. PubMed ID: 29615126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.